Sparsely Ionizing Diagnostic and Natural Background Radiations are Likely Preventing Cancer and other Genomic-Instability-Associated Diseases
Open Access
- 1 July 2007
- journal article
- research article
- Published by SAGE Publications in Dose-Response
- Vol. 5 (3) , 230-55
Abstract
Routine diagnostic X-rays (e.g., chest X-rays, mammograms, computed tomography scans) and routine diagnostic nuclear medicine procedures using sparsely ionizing radiation forms (e.g., beta and gamma radiations) stimulate the removal of precancerous neoplastically transformed and other genomically unstable cells from the body (medical radiation hormesis). The indicated radiation hormesis arises because radiation doses above an individual-specific stochastic threshold activate a system of cooperative protective processes that include high-fidelity DNA repair/apoptosis (presumed p53 related), an auxiliary apoptosis process (PAM process) that is presumed p53-independent, and stimulated immunity. These forms of induced protection are called adapted protection because they are associated with the radiation adaptive response. Diagnostic X-ray sources, other sources of sparsely ionizing radiation used in nuclear medicine diagnostic procedures, as well as radioisotope-labeled immunoglobulins could be used in conjunction with apoptosis-sensitizing agents (e.g., the natural phenolic compound resveratrol) in curing existing cancer via low-dose fractionated or low-dose, low-dose-rate therapy (therapeutic radiation hormesis). Evidence is provided to support the existence of both therapeutic (curing existing cancer) and medical (cancer prevention) radiation hormesis. Evidence is also provided demonstrating that exposure to environmental sparsely ionizing radiations, such as gamma rays, protect from cancer occurrence and the occurrence of other diseases via inducing adapted protection (environmental radiation hormesis).Keywords
This publication has 62 references indexed in Scilit:
- Low-Dose Radiation-Induced Protective Process and Implications for Risk Assessment, Cancer Prevention, and Cancer TherapyDose-Response, 2007
- Stochastic Thresholds: A Novel Explanation of Nonlinear Dose-Response Relationships for Stochastic Radiobiological EffectsDose-Response, 2005
- Radiation Risk Prediction and Genetics: The Influence of the TP53 Gene in vivoDose-Response, 2005
- 131I-Tositumomab Therapy as Initial Treatment for Follicular LymphomaNew England Journal of Medicine, 2005
- Nonlinear Response for Neoplastic Transformation following Low Doses of Low Let RadiationNonlinearity in Biology, Toxicology, Medicine, 2005
- A biological-based model that links genomic instability, bystander effects, and adaptive responseMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2004
- The Bystander Effect: Recent Developments and Implications for Understanding the Dose ResponseNonlinearity in Biology, Toxicology, Medicine, 2004
- Low Doses of Gamma-Radiation Induce Nonlinear Dose Responses in Mammalian and Plant CellsNonlinearity in Biology, Toxicology, Medicine, 2004
- Resveratrol, a tumor‐suppressive compound from grapes, induces apoptosis via a novel mitochondrial pathway controlled by Bcl‐2The FASEB Journal, 2001
- Influence of γ Irradiation on the Development of Neoplastic Disease in Mice: II. Solid TumorsRadiation Research, 1979